Back to search
FDAFDA · Food and drugs·Recall number D-0942-2023

Safe Tussin DM Cough + Chest Congestion (Dextromethorphan HBr/ Cough Suppressant Guaifenesin/Expectorant), packaged in 4.0 FL OZ(118mL), 2020 Kramer Laboratories, Inc. Bridgewater, NJ 08807

Published August 2, 2023 · Recall initiated: June 23, 2023

Summary

FDA records drug Class II recall D-0942-2023, published August 2, 2023 and initiated June 23, 2023. Recalling firm: Kramer Laboratories, Inc.; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 8753, 8753A, Exp. Date 10/2023 Lot #: 8659 Exp. Date 8/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: use of non-food grade lubricant in mixing vessel.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Kramer Laboratories, Inc.
Distributor
nationwide within the United States
Lot
Lot #: 8753, 8753A, Exp. Date 10/2023 Lot #: 8659 Exp. Date 8/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Safe Tussin DM Cough + Chest Congestion (Dextromethorphan HBr/ Cough Suppressant Guaifenesin/Expectorant), packaged in 4.0 FL OZ(118mL), 2020 Kramer Laboratories, Inc. Bridgewater, NJ 08807 recalled?

Yes. FDA published recall D-0942-2023 on August 2, 2023. Reported hazard: CGMP Deviations: use of non-food grade lubricant in mixing vessel.

What should I do if I have this product?

Voluntary: Firm initiated · Letter